ACTISTAT

Welcome to the Brand page for “ACTISTAT”, which is offered here for The mark consists of .;pharmaceutical preparations; sanitary preparations for medical purposes; materials for dressings, bandages for dressings, gauze for dressings, self-adhesive bandages for dressings; pharmaceutical preparations for the prevention and treatment of human diseases; adjuvants for use with vaccines; clotting agents, pharmaceutical preparations for the control of bleeding associated with surgical and medical procedures; clotting preparation, pharmaceutical preparations for the control of bleeding associated with surgical and medical procedures; diagnostic preparations for clinical or medical laboratory use; natural polymers for use in the control of bleeding associated with general surgery, natural polymers for use in the control of bleeding associated with surgery and medical procedures; pharmaceutical preparation for use in halting blood flow and medical procedures, enuresis and blood disorders; plasmin inhibitor; recombinant human thrombin protein as a stand alone product for use as a topical hemostat to control surgical bleeding, for the prophylaxis and treatment of bleeding complications, and alterations in tissue repair associated with certain blood clotting deficiencies; protein involved in the stabilization and strengthening of blood clots developed for the treatment of bleeding complications associated with congenital and acquired deficiencies; preparations which are used either locally, topically or systemically for hemostatic control;.

Its status is currently believed to be active. Its class is unavailable. “ACTISTAT” is believed to be currently owned by “ZYMOGENETICS, INC.”

Owner:
ZYMOGENETICS, INC.
Owner Details
Description:
The mark consists of .;Pharmaceutical preparations; sanitary preparations for medical purposes; materials for dressings, bandages for dressings, gauze for dressings, self-adhesive bandages for dressings; pharmaceutical preparations for the prevention and treatment of human diseases; adjuvants for use with vaccines; clotting agents, pharmaceutical preparations for the control of bleeding associated with surgical and medical procedures; clotting preparation, pharmaceutical preparations for the control of bleeding associated with surgical and medical procedures; diagnostic preparations for clinical or medical laboratory use; natural polymers for use in the control of bleeding associated with general surgery, natural polymers for use in the control of bleeding associated with surgery and medical procedures; pharmaceutical preparation for use in halting blood flow and medical procedures, enuresis and blood disorders; plasmin inhibitor; recombinant human thrombin protein as a stand alone product for use as a topical hemostat to control surgical bleeding, for the prophylaxis and treatment of bleeding complications, and alterations in tissue repair associated with certain blood clotting deficiencies; protein involved in the stabilization and strengthening of blood clots developed for the treatment of bleeding complications associated with congenital and acquired deficiencies; preparations which are used either locally, topically or systemically for hemostatic control;
Categories: